The sale is small and consistent with prior periodic sales by this officer. No material signal for the stock. Monitor for any change in pattern or larger insider sales.
ALKS drugs
ALKS drug pipeline →How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+5- T+0 · Nov 4 $45.89entry
- T+1 · 12d ago −2.94%α +1.47% · $44.54
- T+5 · 6d ago +4.36%α +5.27% · $47.89
- T+8 · todayOpen
- T+20 · in 16d Pending
- T+60 · in 3mo Pending
Price Chart
How similar events traded
Executive Summary
David Gaffin, an officer of Alkermes, filed a Form 144 notice of intent to sell 2,035 shares of common stock, with an estimated aggregate market value of approximately $93,956. The shares were acquired through vesting of restricted stock unit awards between 2015 and 2017. This is a routine, small insider sale relative to the company's $7.6B market cap and the officer's likely holdings.
Key Facts
- David Gaffin, an officer of Alkermes, filed Form 144 on November 3, 2026.
- The proposed sale is for 2,035 shares of common stock.
- Estimated aggregate market value of shares to be sold is $93,955.95.
- Shares were acquired via vesting of restricted stock unit awards on May 21, 2015, May 21, 2016, and March 3, 2017.
- The sale is planned for execution on or about November 3, 2026 through Merrill Lynch.
- The filing also notes four prior sales by the insider within the past three months (June through October 2026), each involving 2,034 shares.
Financial Impact
Proposed sale of 2,035 shares worth ~$94,000, representing less than 0.001% of Alkermes' $7.6B market cap.
Risk Factors
- Insider selling is routine and small; no material risk identified.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001964306-26-000493 |
| Document: 0001964306-26-000493-index.html | 0001964306-26-000493 |
| Document: 0001964306-26-000493.txt | 0001964306-26-000493 |
Track record
23 reports on ALKS
3 of 3 bullish or bearish reports moved the stock their way by T+60. Best: +25.88% at T+60 after the May 12, 2026 report. 3 of 4 went positive at some point.
Filters
- Nov 12, 20264d ago 8-K Neutral 4/10 Entry $46.98 Now $46.53 −0.96% settles Feb 10
- Nov 4, 202612d ago Institutional Cluster Neutral 3/10 Entry $44.54 Now $46.53 +4.47% settles Feb 3
- Nov 3, 202613d ago 144 Neutral 2/10 Viewing Entry $45.89 Now $46.53 +1.39% settles Feb 2
- Nov 3, 202613d ago 8-K Neutral 5/10 Entry $45.69 Now $46.53 +1.84% settles Feb 1
- Sep 21, 20268w ago 8-K Bullish 6/10 Entry $44.00 Now $46.53 +5.76% settles Dec 15
- Sep 16, 20268w ago 8-K Neutral 2/10 Entry $46.07 Now $46.53 +1.00% settles Dec 10
- Sep 3, 202610w ago Insider Cluster Neutral 2/10 Entry $46.10 Now $46.53 +0.93% settles Dec 1
- Aug 3, 202615w ago Insider Cluster Bearish 4/10 Entry $49.67 to $44.32 Now $46.53 +6.32% ▲ +10.77% +11.15% vs SPY
- Aug 3, 202615w ago Insider Cluster Neutral 2/10 Entry $49.67 to $44.32 Now $46.53 −6.32% ▼ −10.77% −11.15% vs SPY
- Aug 3, 202615w ago Insider Cluster Neutral 3/10 Entry $49.67 to $44.32 Now $46.53 −6.32% ▼ −10.77% −11.15% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers